Results from the trial included a 140% average increase in GLP-1 levels in the body leading to an average weight loss of 9 pounds in 8 weeks and up to 25 pounds in 12 weeks in participants.

What Are GLP-1 Medications and How Do They Work? GLP-1 (glucagon-like peptide-1) medications work by mimicking a hormone that regulates blood sugar and appetite. They slow down digestion ...

Dallas-based Smoothie King will blend up five drinks, dubbed “Ozempic Smoothies” that target people taking GLP-1 medications, the company said in an email to The Dallas Morning News.

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Sabrina Weiss is the Editorial Assistant of PEOPLE's food ...

New Resource Offers Tailored Smoothie Menu for Individuals Incorporating GLP-1 Weight Loss Medications into Their Health & Wellness Routines DALLAS, Oct. 29, 2024 /PRNewswire/ -- Smoothie King ...

PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) in patients with ...

Some 12% — or about 1 in 8 — people living in the U.S. have tried a GLP-1 drug, according to a survey by the Kaiser Family Foundation. And with that drug comes many dietary changes that need ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity. HealthDay News — From 2010 to 2023, there was an ...

Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective surgery and gastrointestinal endoscopies, according to new ...

DALLAS —Smoothie King has created a GLP-1 support menu for consumers using the prescription weight-loss drugs. The Dallas-based quick-service restaurant chain said the menu will be available ...

Evoke Pharma (NASDAQ:EVOK) shares rocketed 90% early Monday on positive data for its nasal drug Gimoti in the treatment of stomach paralysis in diabetic patients using GLP-1 drugs. The study ...